ADVANCED GASTRIC AND PANCREATIC CANCER

Clinical trials for ADVANCED GASTRIC AND PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTRIC AND PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for ADVANCED GASTRIC AND PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New 'Living Drug' trial targets tough stomach and pancreatic cancers

Disease control Not yet recruiting

This is an early-stage study testing a new type of personalized immune cell therapy called CBG131 for adults with advanced stomach or pancreatic cancer that has a specific marker (CLDN18.2). The main goals are to find the safest and most effective dose and to see if the treatment…

Matched conditions: ADVANCED GASTRIC AND PANCREATIC CANCER

Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control

Last updated Apr 02, 2026 02:42 UTC

ADVANCED GASTRIC AND PANCREATIC CANCER

Get alerted when new ADVANCED GASTRIC AND PANCREATIC CANCER trials appear

New 'Living Drug' trial targets tough stomach and pancreatic cancers